Impact of lithium treatment on FGF-23 serum concentrations in depressive patients

J Clin Psychopharmacol. 2014 Dec;34(6):745-7. doi: 10.1097/JCP.0000000000000163.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Biomarkers / blood
  • Depressive Disorder / blood*
  • Depressive Disorder / drug therapy*
  • Female
  • Fibroblast Growth Factor-23
  • Fibroblast Growth Factors / blood*
  • Humans
  • Lithium / therapeutic use*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Biomarkers
  • FGF23 protein, human
  • Fibroblast Growth Factors
  • Fibroblast Growth Factor-23
  • Lithium